Announcement out:
MELBOURNE, Australia – May 6, 2008: Prana Biotechnology Limited (NASDAQ: PRAN / ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that it has identified novel therapeutic drug candidates from its Parkinson’s disease program. Already, a lead candidate drug has demonstrated positive effects in pre-clinical studies, protecting the brain from damage to the substantia nigra, the area of the brain affected in Parkinson’s disease.
http://imagesignal.comsec.com.au/asxdata/20080506/pdf/00839699.pdf
trading halt, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $5.503K | 1.808M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 56169934 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 124582868 | 23 |
View Market Depth
| Last trade - 12.21pm 03/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |